Neuroinflammatory reactions in sickness behavior induced by bacterial infection: Protective effect of minocycline
Authors:
- 15 December 2017
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 32 (2)
Abstract
The neurological changes elicited by bacterial infection are called sickness behavior. Minocycline (MIN) is neuroprotective with a remarkable brain tissue penetration. MIN was orally administered at a dose 90 mg/kg for 3 days, whereas Escherichia coli was given as a single intraperitoneal injection (0.2 mL of 24 h growth) on the third day. After 24 h of bacterial infection, behavioral tests namely open field and forced swimming were carried out, then animals were decapitated. Rats infected with E. coli displayed reduced struggling time in forced swimming test, as well as, exploration and locomotion in open field test with reduction in neurotransmitters (norepinephrine, dopamine, and serotonin) versus elevation in the inflammatory (tumor necrosis factor‐alpha, interferon‐gamma) and oxidative stress (thiobarbituric acid reactive substance, reduced glutathione) biomarkers. Inflammatory infiltrates of nuclear cells were observed in brains of infected rats. MIN administration prevented the deleterious effects of E. coli infection, thus protects against sickness behavior possibly via defending from neuroinflammation.Keywords
This publication has 48 references indexed in Scilit:
- Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin TransportersNeuropsychopharmacology, 2010
- Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharideBrain, Behavior, and Immunity, 2009
- Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfoldingPrion, 2009
- Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokinesBrain, Behavior, and Immunity, 2009
- Minocycline and neurodegenerative diseasesBehavioural Brain Research, 2009
- Aluminium-induced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging ratsNeuroToxicology, 2008
- Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicityToxicology, 2008
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injuryAnnals of Neurology, 2002
- Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological DysfunctionNeurosurgery, 2001